Loss-of-function K_Ca2.2 mutations abolish channel activity

Area of Science:

• Neuroscience
• Molecular Biology
• Channelopathies

Background:

• Small-conductance calcium-activated potassium channels subtype 2 (K_Ca2.2) are crucial for neuronal function.
• Genetic mutations in K_Ca2.2 channels are linked to neurodevelopmental disorders like ataxia and tremor.
• Understanding K_Ca2.2 channel dysfunction is vital for addressing these neurological conditions.

Purpose of the Study:

• To investigate the structure-function relationship of rat K_Ca2.2 channels using pathogenic mutations.
• To elucidate the molecular mechanisms underlying K_Ca2.2 channel dysfunction in disease.

Main Methods:

• Heterologous expression of wild-type (WT) and mutant K_Ca2.2 channels in HEK293 cells.
• Electrophysiological recordings to measure channel activity and calcium sensitivity.
• Coexpression experiments to assess dominant-negative effects and rescue by positive modulators.

Main Results:

• Pathogenic K_Ca2.2 mutants, including pore mutations (I360M, Y362C, G363S, I389V) and proline substitutions (L174P, L433P), exhibited no measurable current.
• These mutations dominantly suppressed or abolished the activity of coexpressed K_Ca2.2_WT channels.
• The K_Ca2.2_I289N mutation reduced apparent calcium sensitivity, which was restored by a K_Ca2.2 positive modulator.

Conclusions:

• Pathogenic K_Ca2.2 mutations severely impair channel function, leading to loss-of-function.
• Dominant-negative effects and altered calcium sensitivity contribute to K_Ca2.2 channelopathies.
• K_Ca2.2 positive modulators show therapeutic potential for K_Ca2.2-related neurodevelopmental disorders.